semaglutide compounding news november 2025 Novo Nordisk expands legal action to protect US patients from unsafe, non-FDA-approved compounded "semaglutide" The Semaglutide Shortage Is Ending:

When metabolic health is good, your body can use the energy efficiently, and everything runs smoothly

Insufficient amounts result ultimately in a range of disorders such as types of anaemia and neuropathy (nerve-related problems) especially in our hands and feet

Most GLP-1s are taken by injection, which can lead to irritation or pain at the injection site

The authors of the review presented evidence that sulforaphane protects against carcinogenesis in models of skin, oral, stomach, colon, lung, prostate, and bladder cancer

It converts a dose you have already been given into syringe units it does not set your dose, confirm a peptide is appropriate for you, or replace a clinician